| URL | https://www.masslive.com/coronavirus/2020/12/pfize |
| Source | masslive.com |
| Date Published | 12/12/2020 |
| Author Name | Melissa Hanson |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Pfizer |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Andover |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | covid-19 vaccine |
| What domestic positive factors made reshoring more attractive? | , covid-19 |